Literature DB >> 31318299

Impact of increased resection rates and a liver parenchyma sparing strategy on long-term survival after surgery for colorectal liver metastases. A population-based study.

Per Even Storli1,2, Gjermund Johnsen1, Ingebjørg S Juel1, Jon Erik Grønbech1,2, Erling A Bringeland1,2.   

Abstract

Background and aims: Expanded criteria for resection of colorectal liver metastases (CRLM) have led to a more aggressive surgical attitude. The aim is to evaluate any impact of expanded criteria on perioperative mortality and long-term survival. Materials and methods: A population based study from 2001 to 2015 for patients undergoing surgery for CRLM. The cohort was divided into three 5-year periods.
Results: A total of 341 patients underwent resection of CRLM. Relative to the number of colorectal primaries, patients resected for CRLM increased from 82/2520 (3.3%) in 2001-2005 to 151/3071 (4.9%) in 2011-2015 (p = .007). The proportion of patients who underwent formal resections declined from 62% to 21%. There was a substantial increase in resections of synchronous liver metastases, portal vein embolizations, two-stage resections, and the share of octogenarians who underwent resection. The proportion of patients undergoing reresections of new liver recurrences increased from 6% to 24%. The 90-d postoperative mortality for 2001-2005, 2006-2010, and 2011-2015 were 7.9%, 0.8%, and 2.0%, respectively. The median overall survival was 47 months during the two first periods, for the last period not reached. The 5-year overall survival remained at 40% from 2001 to 2010, and estimated at 55.2% from 2011 to 2015. The 5-year disease-free survival was well above 30%. The 5-year overall survival following liver reresection was 52.6%.
Conclusion: Postoperative mortality remained at approximately 2%, and the 5-year overall survival at 40% in the first 10 years, but increased to 55% in the last 5 years under study, despite a marked increase in resection rates.

Entities:  

Keywords:  Colorectal cancer; liver metastases; population based; resection rate; surgery; survival

Year:  2019        PMID: 31318299     DOI: 10.1080/00365521.2019.1641215

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  2 in total

1.  Influence of diabetes on short-term outcome after major hepatectomy: an underestimated risk?

Authors:  Alexander Fischer; Juri Fuchs; Christos Stravodimos; Ulf Hinz; Adrian Billeter; Markus W Büchler; Arianeb Mehrabi; Katrin Hoffmann
Journal:  BMC Surg       Date:  2020-11-30       Impact factor: 2.102

2.  Modulation of Immune Checkpoints by Chemotherapy in Human Colorectal Liver Metastases.

Authors:  Neda Jabbari; Heidi L Kenerson; Christopher Lausted; Xiaowei Yan; Changting Meng; Kevin M Sullivan; Priyanka Baloni; Dani Bergey; Venu G Pillarisetty; Leroy E Hood; Raymond S Yeung; Qiang Tian
Journal:  Cell Rep Med       Date:  2020-12-22
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.